Sigyn Therapeutics (SIGY) Other Operating Expenses (2017 - 2025)
Sigyn Therapeutics (SIGY) posted Other Operating Expenses of $50052.0 for Q3 2025, little changed sequentially from $50008.0 in Q2 2025, and up 33.07% YoY from $37614.0 in Q3 2024.
Sigyn Therapeutics (SIGY) Other Operating Expenses (2017 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Other Operating Expenses for 9 years, with the latest figure at $50052.0 in Q3 2025.
- Quarterly Other Operating Expenses rose 33.07% year-over-year to $50052.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $38406.0 (up 7328.63% YoY) and the FY2024 annual result came in at $1130.0, up 188.27% from the prior year.
- Other Operating Expenses was little changed at $50052.0 in Q3 2025 per SIGY's latest filing, from $50008.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $105500.0 in Q1 2021 and troughed at -$164500.0 in Q4 2021.
- A 5-year average of $9748.1 and a median of $37575.5 in 2023 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2021 and 2023: Other Operating Expenses soared 100376.19% in 2021, then plunged 1022309.09% in 2023.
- Over 5 years, Other Operating Expenses stood at -$164500.0 in 2021, then surged by 100.01% to $11.0 in 2022, then slumped by 1022309.09% to -$112443.0 in 2023, then advanced by 0.55% to -$111830.0 in 2024, then soared by 144.76% to $50052.0 in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $50052.0, $50008.0, and $50176.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 50,052.00 |
| Jun 30, 2025 | 50,008.00 |
| Mar 31, 2025 | 50,176.00 |
| Dec 31, 2024 | -111,830.00 |
| Sep 30, 2024 | 37,614.00 |
| Jun 30, 2024 | 37,508.00 |
| Mar 31, 2024 | 37,838.00 |
| Dec 31, 2023 | -112,443.00 |
| Sep 30, 2023 | 37,551.00 |
| Jun 30, 2023 | 37,600.00 |
| Mar 31, 2023 | 37,684.00 |
| Dec 31, 2022 | 11.00 |
| Sep 30, 2022 | 65.00 |
| Jun 30, 2022 | 131.00 |
| Mar 31, 2022 | 250.00 |
| Dec 31, 2021 | -164,500.00 |
| Jun 30, 2021 | 82,250.00 |
| Mar 31, 2021 | 105,500.00 |
| Dec 31, 2020 | 200.00 |
| Sep 30, 2020 | 400.00 |